<?xml version="1.0" encoding="UTF-8"?>
<ref id="B42-molecules-25-03830">
 <label>42.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vafaei</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Razmi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Mansoori</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Asadi-Lari</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Madjd</surname>
    <given-names>Z.</given-names>
   </name>
  </person-group>
  <article-title>Spotlight of Remdesivir in Comparison with Ribavirin, Favipiravir, Oseltamivir and Umifenovir in Coronavirus Disease 2019 (COVID-19) Pandemic</article-title>
  <source>Favipiravir Oseltamivir Umifenovir Coronavirus Dis.</source>
  <year>2019</year>
  <pub-id pub-id-type="doi">10.2139/ssrn.3569866</pub-id>
 </element-citation>
</ref>
